Rigel Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. META
5. MU
6. NVDA
7. BLZE
8. IBM
9. PRIM
10. ACN

Go back to Rigel Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

Rigel Pharma (RIGL) Reports In-Line Q4 EPS, Revenues Beat

March 2, 2021 4:21 PM EST

Rigel Pharma (NASDAQ: RIGL) reported Q4 EPS of ($0.11), in-line with the analyst estimate of ($0.11). Revenue for the quarter came in at $18.45 million versus the consensus estimate of $18.1 million.

"Our team has shown its resilience as we continue to execute on our... More